We are live on ! Find out more
RBOT

Vicarious Surgical

Delisted

RBOT was delisted on the 2nd of March, 2026.

98 hedge funds and large institutions have $264M invested in Vicarious Surgical in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,018% more call options, than puts

Call options by funds: $1.91M | Put options by funds: $171K

214% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 14

40% more funds holding

Funds holding: 7098 (+28)

1% more capital invested

Capital invested by funds: $263M → $264M (+$1.46M)

0.07% more ownership

Funds ownership: 2.63%2.7% (+0.07%)

61% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 28

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
98
Holders Change
+28
Holders Change %
+40%
% of All Funds
1.71%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
44
Increased
11
Reduced
28
Closed
14
Calls
$1.91M
Puts
$171K
Net Calls
+$1.74M
Net Calls Change
+$992K
Name Holding Trade Value Shares
Change
Change in
Stake
SMA
51
Sage Mountain Advisors
Georgia
$896K +$892K +2,995 New
OPU
52
Omni Partners US
California
$794K +$791K +2,655 New
EAM
53
Exos Asset Management
New York
$789K +$667K +2,238 +562%
UOC
54
UBS O'Connor
Illinois
$723K -$4.24M -14,249 -85%
BCM
55
BCK Capital Management
Connecticut
$711K
CCM
56
Context Capital Management
California
$606K -$456K -1,530 -43%
CIM
57
Cowen Investment Management
New York
$598K -$397K -1,333 -40%
PCM
58
Prelude Capital Management
New York
$565K +$562K +1,888 New
AA
59
AlphaCentric Advisors
Puerto Rico
$548K +$546K +1,833 New
AGM
60
Alpine Global Management
New York
$515K +$513K +1,722 New
LCM
61
Landscape Capital Management
New Jersey
$498K +$380K +1,276 +329%
MSU
62
Mizuho Securities USA
New York
$496K +$494K +1,657 New
OFG
63
OTA Financial Group
New York
$320K -$125K -421 -28%
MIG
64
Mariner Investment Group
New York
$299K +$298K +1,000 New
HF
65
HRT Financial
New York
$234K -$5.96K -20 -2%
TYCC
66
Texas Yale Capital Corp
Florida
$199K +$199K +667 New
UBS Group
67
UBS Group
Switzerland
$168K +$27.1K +91 +19%
Qube Research & Technologies (QRT)
68
Qube Research & Technologies (QRT)
United Kingdom
$152K -$100K -337 -40%
EIP
69
Easterly Investment Partners
Massachusetts
$150K -$149K -500 -50%
AWM
70
Apollon Wealth Management
South Carolina
$150K +$149K +500 New
Credit Agricole
71
Credit Agricole
France
$150K +$149K +500 New
Verition Fund Management
72
Verition Fund Management
Connecticut
$148K -$51.5K -173 -26%
Wolverine Trading
73
Wolverine Trading
Illinois
$140K +$139K +466 New
NAM
74
Nexpoint Asset Management
Texas
$135K +$134K +450 New
CL
75
CSS LLC
Illinois
$119K -$661K -2,218 -85%

RBOT Hedge Fund Activity: Q2 2021 in Review

98 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q2 2021, worth a combined $264M — up 0.55% from $263M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new RBOT positions and 14 closed out — a net gain of 30 holders — while 11 added to existing stakes and 28 trimmed.

The largest buyer was Sculptor Capital, opening a new position worth an estimated $13.4M. The largest seller was RP Investment Advisors, exiting entirely with an estimated $15.8M sold.

  • 98 institutional investors held Vicarious Surgical (RBOT) as of Q2 2021, up from 70 in Q1 2021.
  • Funds reported $264M of Vicarious Surgical stock for Q2 2021, up 0.55% quarter-over-quarter.
  • 44 funds opened new Vicarious Surgical positions in Q2 2021 and 14 closed out, a net change of +30 holders.
  • The largest Vicarious Surgical buyer in Q2 2021 was Sculptor Capital, an estimated $13.4M added.
  • The largest Vicarious Surgical seller in Q2 2021 was RP Investment Advisors, an estimated $15.8M sold.

Based on aggregated 13F filings for Q2 2021.